Comparison of intravitreal bevacizumab injection and laser photocoagulation for type 1 zone II retinopathy of prematurity

Cheng, 2015, Efficacy of intravitreal injection of anti-vascular endothelial growth factor agents for stage 4 retinopathy of prematurity, Retina, 35, 660, 10.1097/IAE.0000000000000359 Erol, 2015, Comparison of intravitreal ranibizumab and bevacizumab treatment for retinopathy of prematurity, Arq Bras Oftalmol, 78, 340, 10.5935/0004-2749.20150090 Chen, 2015, Intravitreal anti-vascular endothelial growth factor treatment for retinopathy of prematurity: comparison between Ranibizumab and Bevacizumab, Retina, 35, 667, 10.1097/IAE.0000000000000380 Hwang, 2015, Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis, Ophthalmology, 122, 1008, 10.1016/j.ophtha.2014.12.017 Alon, 1995, Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity, Nat Med, 1, 1024, 10.1038/nm1095-1024 Kim, 1993, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature, 362, 841, 10.1038/362841a0 Mintz-Hittner, 2008, Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II, Retina, 28, 831, 10.1097/IAE.0b013e318177f934 Quiroz-Mercado, 2008, Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity, Retina, 28, S19, 10.1097/IAE.0b013e318159ec6b Wu, 2013, An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan, Am J Ophthalmol, 155, 150, 10.1016/j.ajo.2012.06.010 Kabataş, 2017, Comparison of intravitreal bevacizumab, intravitreal ranibizumab and laser photocoagulation for treatment of type 1 retinopathy of prematurity in Turkish preterm children, Curr Eye Res, 42, 1054, 10.1080/02713683.2016.1264607 Mintz-Hittner, 2011, Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity, N Engl J Med, 364, 603, 10.1056/NEJMoa1007374 Yetik, 2015, Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity— 27 month follow-up results from Turkey, Graefes Arch Clin Exp Ophthalmol, 253, 1677, 10.1007/s00417-014-2867-0 Karkhaneh, 2016, Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity, Acta Ophthalmol, 94, e417, 10.1111/aos.13008 Mintz-Hittner, 2009, Antivascular endothelial growth factor for retinopathy of prematurity, Curr Opin Pediatr, 21, 182, 10.1097/MOP.0b013e32832925f9 Mechoulam, 2003, Retinopathy of prematurity: molecular pathology and therapeutic strategies, Am J PharmacoGenomics, 3, 261, 10.2165/00129785-200303040-00004 Lu, 2006, General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain, Apoptosis, 11, 1603, 10.1007/s10495-006-8762-3 Rizzi, 2008, Clinical anesthesia causes permanent damage to the fetal Guinea pig brain, Brain Pathol, 18, 198, 10.1111/j.1750-3639.2007.00116.x Walker, 2006, Neurodevelopmental outcomes and surgery in neonates, J Paediatr Child Health, 42, 749, 10.1111/j.1440-1754.2006.00969.x Ludman, 2001, Educational attainments in early adolescence of infants who required major neonatal surgery, J Pediatr Surg, 36, 858, 10.1053/jpsu.2001.23954 Kabra, 2007, Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms, J Pediatr, 150, 229, 10.1016/j.jpeds.2006.11.039 Wu, 2011, Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan, Ophthalmology, 118, 176, 10.1016/j.ophtha.2010.04.018 Karkhaneh, 2018, Efficacy of intravitreal bevacizumab for the treatment of zone I type 1 retinopathy of prematurity, J Ophthalmic Vis Res, 13, 29, 10.4103/jovr.jovr_198_16 Quinn, 1998, Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prevalence of myopia between 3 months and 5½ years in preterm infants with and without retinopathy of prematurity, Ophthalmology, 105, 1292, 10.1016/S0161-6420(98)97036-1 Quinn, 2008, Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age, Ophthalmology, 115, 10.1016/j.ophtha.2007.07.028 Quinn, 2013, Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings at 4 to 6 years of age, J AAPOS, 17, 124 McLoone, 2006, Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity, J AAPOS, 10, 454 Quinn, 2001, Ophthalmology, 108, 343, 10.1016/S0161-6420(00)00527-3 Geloneck, 2014, BEAT-ROP Cooperative Group. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial, JAMA Ophthalmol, 132, 1327, 10.1001/jamaophthalmol.2014.2772 Gunay, 2017, Comparison of bevacizumab, ranibizumab, and laser photocoagulation in the treatment of retinopathy of prematurity in Turkey, Curr Eye Res, 42, 462, 10.1080/02713683.2016.1196709 Kuo, 2015, Refractive error in patients with retinopathy of prematurity after laser photocoagulation or bevacizumab monotherapy, Ophthalmologica, 234, 211, 10.1159/000439182 Hong, 2015, Plasma concentrations of vascular endothelial growth factor in retinopathy of prematurity after intravitreal bevacizumab injection, Retina, 35, 1772, 10.1097/IAE.0000000000000535 Gerber, 1999, VEGF is required for growth and survival in neonatal mice, Development, 126, 1149, 10.1242/dev.126.6.1149 Teng, 2008, Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke, J Cerebr Blood Flow Metabol, 28, 764, 10.1038/sj.jcbfm.9600573 Chen, 2018, A spectrum of regression following intravitreal bevacizumab in retinopathy of prematurity, Am J Ophthalmol Toy, 2016, Chronic vascular arrest as a predictor of bevacizumab treatment failure in retinopathy of prematurity, Ophthalmology, 123, 2166, 10.1016/j.ophtha.2016.06.055